PLOSopen access
PrP turnover in vivo and the time to effect of prion disease therapeutics
cerebrospinal fluid, colon, cerebrospinal fluid, lysine, genetically modified animals, mammalian genomics
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 228202
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.